Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease.
暂无分享,去创建一个
James T Becker | Lewis H Kuller | Oscar L Lopez | Paul M Thompson | William F Eddy | W. Eddy | P. Thompson | J. Becker | L. Kuller | O. Lopez | C. Raji | Lubov E Zeifman | Cyrus Raji | P. Thompson | P. Thompson | P. Thompson
[1] Alan J. Thomas,et al. Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.
[2] J. Becker,et al. Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old , 2014, Neurology.
[3] V. Johnson. Revised standards for statistical evidence , 2013, Proceedings of the National Academy of Sciences.
[4] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[5] Owen Carmichael,et al. Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study–Cognition Study , 2012, Neurology.
[6] J. Gunter,et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease , 2012, Neurology.
[7] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[8] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[9] James T. Becker,et al. Magnetoencephalography as a Putative Biomarker for Alzheimer's Disease , 2011, International journal of Alzheimer's disease.
[10] Clifford R. Jack,et al. Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD , 2011, NeuroImage.
[11] Masaki Mogi,et al. Clinical Interaction between Brain and Kidney in Small Vessel Disease , 2011, Cardiology research and practice.
[12] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[13] Oscar L. Lopez,et al. Telephone Interview for Cognitive Status , 2009, Neuroepidemiology.
[14] Henri A. Vrooman,et al. Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences: Rotterdam Scan Study , 2008, Stroke.
[15] Oscar L. Lopez,et al. Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease , 2008, Alzheimer's & Dementia.
[16] Owen Carmichael,et al. Trajectories of brain loss in aging and the development of cognitive impairment , 2008, Neurology.
[17] Paul M. Thompson,et al. Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils , 2008, NeuroImage.
[18] Owen Carmichael,et al. Acceleration of cerebral ventricular expansion in the Cardiovascular Health Study , 2007, Neurobiology of Aging.
[19] Minjie Wu,et al. Focal Atrophy and Cerebrovascular Disease Increase Dementia Risk among Cognitively Normal Older Adults , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[20] C. Kawas,et al. Alzheimer's and dementia in the oldest-old: a century of challenges. , 2006, Current Alzheimer research.
[21] M. Onofrj,et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.
[22] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[23] Alex Kiss,et al. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years , 2005, Neurology.
[24] J. Morris,et al. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. , 2005, Archives of neurology.
[25] Oscar L. Lopez,et al. Survival following dementia onset: Alzheimer's disease and vascular dementia , 2005, Journal of the Neurological Sciences.
[26] Norman J Beauchamp,et al. Incidence, Manifestations, and Predictors of Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2005, Stroke.
[27] H Rusinek,et al. Atrophy rate in medial temporal lobe during progression of Alzheimer disease , 2004, Neurology.
[28] C. Lyketsos,et al. P4-039 Clinical and MRI factors for vascular dementia in the cardiovascular health study cognition study , 2004, Neurobiology of Aging.
[29] Lewis H Kuller,et al. Incidence and Prevalence of Dementia in the Cardiovascular Health Study , 2004, Journal of the American Geriatrics Society.
[30] John Breitner,et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. , 2003, Archives of neurology.
[31] A. Hofman,et al. Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.
[32] Jean-Claude Baron,et al. Early diagnosis of alzheimer’s disease: contribution of structural neuroimaging , 2003, NeuroImage.
[33] Nick C Fox,et al. Assessing the onset of structural change in familial Alzheimer's disease , 2003, Annals of neurology.
[34] Oscar L. Lopez,et al. Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.
[35] Oscar L. Lopez,et al. Evaluation of Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.
[36] M H Buonocore,et al. Brain structure and cognition in a community sample of elderly Latinos , 2002, Neurology.
[37] William J Jagust,et al. Brain function and cognition in a community sample of elderly Latinos , 2002, Neurology.
[38] A Hofman,et al. Hypertension and cerebral white matter lesions in a prospective cohort study. , 2002, Brain : a journal of neurology.
[39] N. Schuff,et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[40] A. Convit,et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.
[41] E Auffray,et al. Longitudinal study of blood pressure and white matter hyperintensities , 2001, Neurology.
[42] J. Price,et al. Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.
[43] Roberta F. White,et al. The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.
[44] R. Killiany,et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease , 2000, Annals of neurology.
[45] Nick Bryan,et al. Clinical Correlates of Ventricular and Sulcal Size on Cranial Magnetic Resonance Imaging of 3,301 Elderly People , 1999, Neuroepidemiology.
[46] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[47] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[48] T. Manolio,et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults : the Cardiovascular Health Study. CHS Collaborative Research Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[49] D E Kuhl,et al. Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. , 1999, Journal of psychiatric research.
[50] C. DeCarli,et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology , 1998, Neurology.
[51] Alan C. Evans,et al. Enhancement of MR Images Using Registration for Signal Averaging , 1998, Journal of Computer Assisted Tomography.
[52] L. Fried,et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. , 1998, Stroke.
[53] C. Jack,et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.
[54] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[55] F. Barkhof,et al. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging , 1995, Neurology.
[56] Teri,et al. A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. , 1994, AJNR. American journal of neuroradiology.
[57] H. Soininen,et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age‐associated memory impairment , 1994, Neurology.
[58] L. Thal,et al. A validation study of the Dementia Questionnaire. , 1994, Archives of neurology.
[59] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[60] D L Patrick,et al. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). , 1994, American journal of preventive medicine.
[61] E P Steinberg,et al. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. , 1994, Stroke.
[62] Gwenn S. Smith,et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. , 1993, AJNR. American journal of neuroradiology.
[63] W. Jagust,et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.
[64] Scott T. Grafton,et al. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. , 1991, Archives of neurology.
[65] J. Meyer,et al. Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging. , 1990, Archives of neurology.
[66] Anthony F Jorm,et al. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms , 1989, Psychological Medicine.
[67] H. Chui,et al. The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.
[68] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[69] J. Morris,et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup , 2011 .
[70] A. Toga,et al. Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. , 2006, Archives of neurology.
[71] A. Hofman,et al. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. , 2006, Archives of general psychiatry.
[72] J. Cummings,et al. Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.
[73] V. Henderson,et al. Diagnosis and Treatment of Alzheimer's Disease , 2005 .
[74] Cees Jonker,et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.
[75] 浜田賀代子,et al. 老年期痴呆患者のスクリーニングにおけるThe modified mini-mental state (3MS) examination日本語版の有用性 , 1992 .